Dare Bioscience Inc (DARE)

Apr 23, 2025

Daré Bioscience to Present at the Fierce Pharma Engage - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Daré CEO Unveils Game-Changing Women's Health Pipeline: Sildenafil Cream Launch Timeline Confirmed - Stock Titan

Apr 23, 2025

Apr 12, 2025

Daré Bioscience (NASDAQ:DARE) Share Price Crosses Below 200-Day Moving Average – Here’s What Happened - Defense World

Apr 12, 2025

Apr 12, 2025

Dare Bioscience granted extension by Nasdaq to regain compliance - Investing.com Australia

Apr 12, 2025

Apr 07, 2025

Daré Bioscience to Present at the Jones Healthcare and - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

Daré's Game-Changing Strategy: Sildenafil Cream Heads to Prescription Market Earlier Than Expected - Stock Titan

Apr 07, 2025

Apr 05, 2025

Daré Bioscience Q1 EPS Estimate Increased by HC Wainwright - Defense World

Apr 05, 2025

Apr 04, 2025

Q1 EPS Estimate for Daré Bioscience Decreased by Analyst - Defense World

Apr 04, 2025

Apr 04, 2025

HC Wainwright Forecasts Daré Bioscience FY2029 Earnings - Defense World

Apr 04, 2025

Apr 04, 2025

Short Interest in Daré Bioscience, Inc. (NASDAQ:DARE) Rises By 22.2% - Defense World

Apr 04, 2025

Apr 02, 2025

Daré Bioscience (NASDAQ:DARE) Receives Buy Rating from HC Wainwright - Defense World

Apr 02, 2025

Apr 01, 2025

Daré Bioscience Earnings Call: Strategic Progress Amid Challenges - TipRanks

Apr 01, 2025

Apr 01, 2025

Daré Bioscience (DARE) Anticipates Revenue Boost from Sildenafil Cream in 2025 - GuruFocus

Apr 01, 2025

Apr 01, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

Dare Bioscience Inc (DARE) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Home

Apr 01, 2025

Mar 31, 2025

Earnings call transcript: Dare Bioscience Q4 2024 focuses on women’s health innovations - Investing.com

Mar 31, 2025

Mar 31, 2025

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

Dare Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Mar 31, 2025

Daré Bioscience Reports Full Year 2024 Financial Results - MarketScreener

Mar 31, 2025

Mar 31, 2025

DARE BIOSCIENCE Earnings Results: $DARE Reports Quarterly Earnings - Nasdaq

Mar 31, 2025

Mar 31, 2025

Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update - TradingView

Mar 31, 2025

Mar 31, 2025

Daré Bioscience Reveals New Revenue Strategy: Sildenafil Cream Launch Coming Q4 2025 - Stock Titan

Mar 31, 2025

Mar 28, 2025

Daré Bioscience (NASDAQ:DARE) Stock Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World

Mar 28, 2025

Mar 24, 2025

Upcoming: Daré Bioscience Full Year Results Reveal Women's Health Innovation Progress - StockTitan

Mar 24, 2025

Mar 24, 2025

Daré Bioscience to Host Full Year 2024 Financial Results - GlobeNewswire

Mar 24, 2025

Mar 20, 2025

Daré Bioscience (DARE) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 15, 2025

Daré Bioscience (NASDAQ:DARE) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World

Mar 15, 2025

Feb 20, 2025

Dare Bioscience, Inc. to Host Earnings Call - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Daré Bioscience and Theramex Announce Co-Development and - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Dare Bioscience and Theramex Announce Co-Development and Licensing Agreement for A Potential Biodegradable Long-Acting Contraceptive Implant - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Daré, Theramex partner on biodegradable contraceptive implant - Investing.com

Feb 20, 2025

Feb 20, 2025

Daré, Theramex partner on biodegradable contraceptive implant By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

Revolutionary Contraceptive Tech: This New Implant Actually Dissolves After Use - StockTitan

Feb 20, 2025

Feb 14, 2025

Dare Bioscience risks Nasdaq delisting over market value - MSN

Feb 14, 2025

Feb 12, 2025

Dare Bioscience (NASDAQ: DARE) Files 8-K with SEC Regarding Corporate Presentation - Defense World

Feb 12, 2025

Feb 10, 2025

Daré Bioscience to Present at BIO CEO Conference - TipRanks

Feb 10, 2025

Feb 07, 2025

Dare Bioscience secures additional NIAID funding for HPV treatment - MSN

Feb 07, 2025

Feb 07, 2025

Dare Bioscience secures additional NIAID funding for HPV treatment By Investing.com - Investing.com Nigeria

Feb 07, 2025

Feb 06, 2025

Daré Bioscience Announces Funding Award Notice from the - GlobeNewswire

Feb 06, 2025

Feb 06, 2025

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development - The Manila Times

Feb 06, 2025

Feb 06, 2025

Revolutionary HPV Treatment Gets $12M Funding Boost: A New Hope for Cervical Health - StockTitan

Feb 06, 2025

Jan 28, 2025

Daré Bioscience (NASDAQ:DARE) Shares Cross Below 200-Day Moving Average – Time to Sell? - Defense World

Jan 28, 2025

Jan 20, 2025

Daré Bioscience (NASDAQ:DARE) Prepares to Share Corporate Presentation on January 13, 2025 - Defense World

Jan 20, 2025

Jan 14, 2025

Geode Capital Management LLC Decreases Stock Holdings in Daré Bioscience, Inc. (NASDAQ:DARE) - Defense World

Jan 14, 2025

Jan 14, 2025

Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average – Time to Sell? - Defense World

Jan 14, 2025

Jan 13, 2025

Daré Bioscience Announces New Corporate Presentation - TipRanks

Jan 13, 2025